Sanofi Aventis Us

Related News »
HONG KONG (Reuters) - Sanofi-Aventis plans to begin testing a novel compound that is designed to starve liver cancer to death in a phase one human clinical trial in China and possibly South Korea in 2013. The compound, called slit-trap ...
May 24, 2012 at 09:17 | Source: Reuters India
Law360, New York (May 21, 2012, 2:05 PM ET) -- Bristol-Myers Squibb Co. and Sanofi-Aventis US LLC on Friday urged a judge to toss a suit accusing the drugmakers of deceptively marketing their blockbuster blood thinner Plavix and causing patients to overpay ...
May 21, 2012 at 18:03 | Source: site.law360.com
These generic Clopidogrel Tablets USP, 75 mg. are therapeutic equivalents of Plavix® tablets from Sanofi-Aventis. Clopidogrel Tablets have annual sale of approximately $ 6.7 billion in the US. Clopidogrel Tablets USP, are indicated for Acute ...
May 18, 2012 at 11:54 | Source: Phramalive.com
The US is expected to lead the Pharmaceuticals industry in ... by value, 2010 176 Table 113: Sanofi-Aventis SA: key facts 196 Table 114: Sanofi-Aventis SA: key financials ($) 197 Table 115: Sanofi-Aventis SA: key financials (€) 197 Table ...
May 23, 2012 at 10:37 | Source: Sacramento Bee
An antiplatelet agent used to reduce the risk of stroke or heart attack in patients with atherosclerosis, Plavix has a $6-billion market in the US. It is sold by Bristol-Myers Squibb and Sanofi-Aventis. “It should give a major boost to the company’s ...
May 16, 2012 at 18:59 | Source: Business Standard
A blood-thinning drug, Plavix's US patent expired yesterday, clearing the way for generic versions of the drug. Clopidogrel is the generic version of Sanofi-Aventis' Plavix, and is indicated for acute coronary syndrome and for patients with a ...
May 17, 2012 at 23:58 | Source: in.com
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe ... (2008): Market Share Breakdown by Value Sales forGlaxoSmithKline, Sanofi-Aventis, Merck & Co., Novartis,Wyeth, and Others (includes corresponding Graph ...
May 16, 2012 at 09:55 | Source: Yahoo Finance
Rhabdomyolysis a Muscle symptoms with significant CK elevation (typically >10 times ULN), and creatinine elevation (usually with brown urine and urinary myoglobin) a US Food and Drug ... Roche, Sanofi-Aventis and Servier. He has acted as a ...
May 22, 2012 at 20:03 | Source: Medscape News
The net profit of 15 companies increased by 12.8 per cent to US$ 97 billion during 2011 from $86 billion ... Associate Vice President of Leadership and Management Development at Sanofi-Aventis, "The most important result of the changing sales structure ...
May 22, 2012 at 14:20 | Source: PRLog (free press release)
Clopidogrel tablets USP 75 mg is the generic equivalent of Aventis US LLC (Sanofi)'s Plavix tablets USP 75 mg. The product falls under the cardio-vascular (CVS) therapeutic category and is indicated for the prevention of atherothrombotic events in patients ...
May 18, 2012 at 07:44 | Source: RTT News